- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x RB6: (2R)-2-[(1R)-1-{[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino}-2-oxoethyl]-5-({2-oxo-1-[(3R)-pyr rolidin-3-yl]-2,5-dihydro-1H-pyrrol-3-yl}methyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid(Covalent)
- 4 x BCT: BICARBONATE ION(Non-functional Binders)
BCT.2: 4 residues within 4Å:- Chain A: R.129, T.143, R.219, V.255
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:T.143, A:R.219
BCT.3: 4 residues within 4Å:- Chain A: D.106, H.107, Q.115, K.116
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:D.106, A:H.107, A:K.116, A:K.116
BCT.4: 4 residues within 4Å:- Chain A: K.131, D.301
- Chain B: K.131, D.301
No protein-ligand interaction detected (PLIP)BCT.11: 3 residues within 4Å:- Chain B: D.13, E.16, R.61
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.16, B:R.61
- 7 x CD: CADMIUM ION(Non-covalent)
CD.5: 5 residues within 4Å:- Chain A: H.121, E.123
- Chain B: E.123
- Ligands: CL.8, CD.12
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Metal complexes: A:H.121, A:E.123, B:E.123, B:E.123
CD.6: 1 residues within 4Å:- Chain A: H.210
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:H.210
CD.7: 4 residues within 4Å:- Chain A: G.113, H.289
- Chain B: D.187
- Ligands: CL.9
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Metal complexes: A:G.113, A:H.289, B:D.187, B:D.187
CD.12: 6 residues within 4Å:- Chain A: E.123
- Chain B: H.121, E.123, N.285
- Ligands: CD.5, CL.16
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain A- Metal complexes: B:H.121, B:E.123, A:E.123, A:E.123
CD.13: 5 residues within 4Å:- Chain A: D.187
- Chain B: G.113, Q.115, H.289
- Ligands: CL.17
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain A- Metal complexes: B:G.113, B:H.289, A:D.187, A:D.187
CD.14: 1 residues within 4Å:- Chain B: H.210
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:H.210
CD.15: 2 residues within 4Å:- Chain B: N.547, D.551
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:D.551, B:D.551
- 4 x CL: CHLORIDE ION(Non-functional Binders)
CL.8: 6 residues within 4Å:- Chain A: H.121, E.123, T.278, V.280
- Chain B: E.123
- Ligands: CD.5
Ligand excluded by PLIPCL.9: 8 residues within 4Å:- Chain A: G.113, Q.115, Q.118, A.288, H.289
- Chain B: Q.185, D.187
- Ligands: CD.7
Ligand excluded by PLIPCL.16: 7 residues within 4Å:- Chain A: E.123
- Chain B: H.121, E.123, R.276, T.278, V.280
- Ligands: CD.12
Ligand excluded by PLIPCL.17: 8 residues within 4Å:- Chain A: Q.185, D.187
- Chain B: G.113, Q.115, Q.118, A.288, H.289
- Ligands: CD.13
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lovering, A.L. et al., Structural Insights into the Anti-methicillin-resistant Staphylococcus aureus (MRSA) Activity of Ceftobiprole. J.Biol.Chem. (2012)
- Release Date
- 2012-08-01
- Peptides
- Penicillin-binding protein 2': AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x RB6: (2R)-2-[(1R)-1-{[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino}-2-oxoethyl]-5-({2-oxo-1-[(3R)-pyr rolidin-3-yl]-2,5-dihydro-1H-pyrrol-3-yl}methyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid(Covalent)
- 4 x BCT: BICARBONATE ION(Non-functional Binders)
- 7 x CD: CADMIUM ION(Non-covalent)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lovering, A.L. et al., Structural Insights into the Anti-methicillin-resistant Staphylococcus aureus (MRSA) Activity of Ceftobiprole. J.Biol.Chem. (2012)
- Release Date
- 2012-08-01
- Peptides
- Penicillin-binding protein 2': AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B